CSIR-IICT, Lee Pharma sign agreement to produce 2-D
Lee Pharma has entered into a non-exclusive licensing agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) recently developed by DRDO and Dr Reddy's Laboratories to treat COVID patients, informed a statement
CSIR-IICT, Lee Pharma Sign Agreement To Produce 2- | 11/06/2021 | By Darshana | 218
CSIR-IICT, Lee Pharma sign agreement to produce 2-D
Lee Pharma has entered into a non-exclusive licensing agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) recently developed by DRDO and Dr Reddy's Laboratories to treat COVID patients, informed a statement
CSIR-IICT, Lee Pharma Sign Agreement To Produce 2- | 11/06/2021 | By Darshana | 218
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy